<DOC>
	<DOCNO>NCT00171483</DOCNO>
	<brief_summary>Study assess effect tegaserod add PPI therapy resolution heartburn regurgitation patient incomplete relief PPIs .</brief_summary>
	<brief_title>Assessment Role Tegaserod Therapy Management Gastroesophageal Reflux Disease ( GERD ) Symptoms Patients With Incomplete Response Proton Pump Inhibitors ( PPIs ) .</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<criteria>Heartburn least 3 day week prior screen Regurgitation least 3 day week prior screen Stable dose PPI therapy &gt; 4 week Incomplete relief daily PPI therapy &gt; 4 week Evidence structural abnormality gastrointestinal tract disease/conditions Previous gastrointestinal surgery may influence esophageal motor function Evidence cathartic colon history laxative use Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>GERD</keyword>
	<keyword>PPI</keyword>
	<keyword>heartburn</keyword>
	<keyword>regurgitation</keyword>
</DOC>